지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2000.6
- 수록면
- 103 - 110 (8page)
이용수
초록· 키워드
오류제보하기
In this study, the author prospectively analyzed the effects of SSRIs, RIMA(moclobemide) and SSRE (tianeptine) on sexual function using a questionnaire.
Among patients who visited the outpatient department of Kyungpook University Hospital from November 1998 to May 2000, the author included patients who met DSM-Ⅳ diagnostic criteria for depressive disorder. Sexual function and satisfaction was evaluated using a series of questions asked of each patient every 2 weeks for 8 weeks.
Among 24 patients who completed the full 8 weeks of treatment, 8 received tianeptine(men 3, women 5), 7 received moclobemide(men 3, women 4), and 9 received SSRIs(men 6, women 3).
Of 8 tianeptine group, 7 reported total improvement in sexual function and satisfaction comparable to premorbid condition within 4 weeks of treatment, and another woman who had not experienced substantial improvement till 8 weeks had good tolerance in sexual function and reported some improvement in lubrication. Of 7 moclobemide group, 5 reported no significant differences in their sexual function associated with medication. In SSRI group, all patients complained of delayed ejaculation and anorgasmia associated with medication within 4 weeks of treatment, and among them 2 reported decreased libido and difficulty in erection (lubrication) in addition. But at 8 weeks, except for 1 female patient who couldn't tolerate general sexual dysfunction(especially anorgasmia) and was switched over to another antidepressant, 5 male patients reported no significant differences in their sexual function.
The result of this study demonstrated that sexual dysfunction associated with SSRIs might be adapted in most cases when taken continuously and moclobemide had no significant association with sexual dysfunction. Tianeptine, in most depressive patients, recovered general sexual function including libido, erection (lubrication), ejaculation and orgasm to premorbid condition and might be a desirable drug of choice and an altemative in patients who complain of sexual dysfunction.
Among patients who visited the outpatient department of Kyungpook University Hospital from November 1998 to May 2000, the author included patients who met DSM-Ⅳ diagnostic criteria for depressive disorder. Sexual function and satisfaction was evaluated using a series of questions asked of each patient every 2 weeks for 8 weeks.
Among 24 patients who completed the full 8 weeks of treatment, 8 received tianeptine(men 3, women 5), 7 received moclobemide(men 3, women 4), and 9 received SSRIs(men 6, women 3).
Of 8 tianeptine group, 7 reported total improvement in sexual function and satisfaction comparable to premorbid condition within 4 weeks of treatment, and another woman who had not experienced substantial improvement till 8 weeks had good tolerance in sexual function and reported some improvement in lubrication. Of 7 moclobemide group, 5 reported no significant differences in their sexual function associated with medication. In SSRI group, all patients complained of delayed ejaculation and anorgasmia associated with medication within 4 weeks of treatment, and among them 2 reported decreased libido and difficulty in erection (lubrication) in addition. But at 8 weeks, except for 1 female patient who couldn't tolerate general sexual dysfunction(especially anorgasmia) and was switched over to another antidepressant, 5 male patients reported no significant differences in their sexual function.
The result of this study demonstrated that sexual dysfunction associated with SSRIs might be adapted in most cases when taken continuously and moclobemide had no significant association with sexual dysfunction. Tianeptine, in most depressive patients, recovered general sexual function including libido, erection (lubrication), ejaculation and orgasm to premorbid condition and might be a desirable drug of choice and an altemative in patients who complain of sexual dysfunction.
목차
영어 초록
서론
연구대상 및 방법
결과
고찰
결론
참고문헌
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
여성의 성기능 장애와 성 스트레스, 성태도 및 성지식과의 관계 연구
Women's Health Nursing
2004 .01
-
Comparison of Treatment Adherence between Selective Serotonin Reuptake Inhibitors and Moclobemide in Patients with Social Anxiety Disorder
PSYCHIATRY INVESTIGATION
2012 .01
-
항우울제 치료에 의한 성기능 부작용 : Serotonin-Specific Reuptake Inhibitor 중심으로
생물치료정신의학
1999 .12
-
중년여성의 성기능 장애에 영향을 미치는 요인
보건의료산업학회지
2012 .01
-
항우울제의 부작용과 대처 방안(1) - 성기능 장애를 중심으로 -
생물정신의학
2006 .01
-
Mirtazapine Augmentation for Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: A Retropective Investigation
PSYCHIATRY INVESTIGATION
2011 .01
-
중년여성의 성 기능과 성 디스트레스 양상: 서울시 거주 여성을 대상으로
Women's Health Nursing
2007 .01
-
당뇨여성의 성기능 장애 조사연구
재활간호학회지
2007 .06
-
Sexual Desire, Sexual Function, and Quality of Life in Married Women with Hypoactive Sexual Desire Disorder
보건교육건강증진학회지
2013 .12
-
뇌졸중 후 성생활의 임상양상
Annals of Rehabilitation Medicine
2005 .01
-
Sexual Dysfunction in Patients with Polycystic Ovary Syndrome in Malaysia
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
자궁절제술을 받은 여성과 배우자의 성생활
Women's Health Nursing
2001 .01
-
1회 2회 분복 투여하는 Moclobemide의 효과와 안전성 : 주요우울장애 환자에서 개방 시험
생물정신의학
1996 .01
-
뇌졸중 후 일반적 특성과 관련된 성기능의 변화
대한물리치료학회지(JKPT)
2009 .01
-
SSRIs 이후의 항우울제
생물정신의학
1999 .01
-
여성 성기능장애
Obstetrics & Gynecology Science
2006 .01
-
Walker와 Avant 방법에 근거한 여성의 성 주체성 개념분석
Women's Health Nursing
2017 .01
-
중년 직장여성의 성기능에 미치는 골반저근운동의 효과: 예비연구
기본간호학회지
2007 .11
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2009-513-017216416